ClinicalTrials.gg
CompletedNCT07870317Updated Oct 13, 2026

450 nm Blue Diode Laser Versus Blue LED for In-Office Tooth Bleaching

An interventional study of 450 nm Blue Diode Laser and Blue Light-Emitting Diode Lamp in Tooth Discoloration, sponsored by Misr University for Science and Technology. Completed at 1 site in Egypt. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Misr University for Science and Technology · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Sep 2024, registered Oct 2026).
Updated Oct 13, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

Tooth discoloration is commonly managed using in-office dental bleaching. This randomized clinical trial compared the efficacy and safety of activating the same 35% hydrogen peroxide bleaching gel with either a 450 nm blue diode laser or a conventional blue light-emitting diode lamp. Forty participants aged 18 to 25 years were randomly assigned in a 1:1 ratio to one of the two interventions. The primary outcome was postoperative tooth hypersensitivity immediately after treatment. Secondary outcomes included immediate tooth-color change, color stability at 4 weeks, 8 weeks, and 6 months, gingival irritation, and patient satisfaction. Participants and outcome assessors were blinded to group allocation, whereas the treating operator could not be blinded because the devices were visibly different.

Read the detailed description

This participant- and outcome-assessor-blinded, parallel-group randomized clinical trial evaluated two methods of photoactivating an in-office dental bleaching agent. Participants underwent medical and dental assessment and professional gingival decontamination one week before bleaching.

Participants were assigned to either a 450 nm blue diode laser group or a blue LED group. Both groups received a 35% hydrogen peroxide bleaching gel. In the laser group, the gel was activated using a TRIPLO 450 nm blue diode laser operated at 1.5 W in continuous-wave mode with an 8 mm handpiece tip for 30 seconds per tooth. Three bleaching cycles were performed, with the gel removed after each cycle. In the comparator group, the same bleaching gel was activated using the BlancOne ARCUS blue LED lamp according to the manufacturer's protocol.

Tooth color was assessed before treatment, immediately after treatment, and at 4 weeks, 8 weeks, and 6 months. Postoperative hypersensitivity was assessed immediately after treatment using a visual analogue scale. Gingival irritation and participant satisfaction were assessed using verbal rating measures. Participants, questionnaire collectors, tooth-color assessors, and the statistical analyst were blinded to group allocation. The operator administering the interventions was not blinded.

02

Conditions studied

  • Tooth Discoloration

Keywords

  • Dental bleaching
  • Tooth whitening
  • 450 nm blue diode laser
  • Blue light-emitting diode
  • Tooth hypersensitivity
  • Color stability
03

In context

Tooth Discoloration

107 studies on the registry are indexed under Tooth Discoloration; 19 are open to participants now.

This study's enrollment of 40 is below the median of 46 across 99 interventional studies indexed under Tooth Discoloration.

Browse Tooth Discoloration studies →

Lead sponsor

Misr University for Science and Technology is the lead sponsor of 38 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adults aged 18 to 25 years.
  2. Male or female.
  3. Medically healthy.
  4. Fair oral hygiene.
  5. Able and willing to cooperate with treatment and follow-up instructions.
  6. No previous tooth-bleaching treatment.
  7. Natural maxillary and mandibular teeth extending from the right second premolar to the left second premolar.
  8. No restorations involving the teeth evaluated in the study.
  9. Baseline tooth shade A2 or darker according to the VITA Classical shade guide.
  10. Willing to maintain a consistent pattern of consuming chromogenic foods and beverages during follow-up.

Exclusion criteria

Exclusion Criteria:

  1. Multiple crowns or fixed dental prostheses involving the evaluated teeth.
  2. Multiple composite restorations involving the evaluated teeth.
  3. Excessive alcohol or coffee intake.
  4. Chronic heavy smoking.
  5. Severe periodontal disease.
  6. Developmental or post-eruptive enamel abnormalities, including amelogenesis imperfecta.
  7. Endodontically treated teeth within the treatment area.
  8. Pre-existing tooth hypersensitivity.
  9. Active infection at the planned bleaching site.
  10. Known allergy to any component of the bleaching products.
  11. Pregnancy or lactation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    450 nm Blue Diode Laser Activation

    Participants underwent in-office tooth bleaching with 35% hydrogen peroxide gel activated using a 450 nm blue diode laser. The laser was operated at 1.5 W in continuous-wave mode through an 8 mm handpiece tip for 30 seconds per tooth. Three bleaching cycles were performed, with the gel removed after each cycle.

    Device: 450 nm Blue Diode Laser · Drug: 35% Hydrogen Peroxide Dental Bleaching Gel

  • Active comparator
    Blue LED Activation

    Participants underwent in-office tooth bleaching with the same 35% hydrogen peroxide gel activated using a blue LED lamp according to the manufacturer's recommended protocol. The LED was placed at 5-10cm from the mouth for a period of 24 minutes. The bleaching gel was simultaneously activated on both arches, including the sides, without any operator intervention. The bleaching session consisted of three cycles. The gel was photoactivated for 8 minutes during each cycle.

    Device: Blue Light-Emitting Diode Lamp · Drug: 35% Hydrogen Peroxide Dental Bleaching Gel

Interventions

  • Device450 nm Blue Diode Laser

    A 450 nm blue diode laser was used to activate the dental bleaching gel. The device was operated at 1.5 W in continuous-wave mode using a therapy handpiece with an 8 mm tip connected to an optical fiber. Irradiation was delivered for 30 seconds per tooth. Three bleaching cycles were performed.

    Also known as: TRIPLO, Medency

  • DeviceBlue Light-Emitting Diode Lamp

    A blue light-emitting diode lamp was used to activate the dental bleaching gel. The device was operated according to the manufacturer's recommended protocol, The lamp was oriented perpendicularly to the teeth at a distance of 5-10 cm from the mouth to guarantee adequate airflow. The bleaching session consisted of three cycles. The gel was photoactivated for 8 minutes during each cycle.

    Also known as: BlancOne ARCUS

  • Drug35% Hydrogen Peroxide Dental Bleaching Gel

    The same 35% hydrogen peroxide dental bleaching gel was applied in both study arms. The bleaching session consisted of three cycles. The gel was photoactivated for 8 minutes during each cycle.

    Also known as: BlancOne ULTRA+

06

What researchers measure

Primary outcomes

  1. Postoperative Tooth Hypersensitivity Assessed Using a Visual Analogue Scale

    Participants rated tooth hypersensitivity using a visual analogue scale. The VAS outlines six The patients were asked to select the option that most accurately reflects their amount of discomfort or pain experienced. The scores of 0 (no pain), 1(little), 2 (mild), 3 (moderate), 4 (severe), 5 (very severe), and 6 (unbearable) were sequentially awarded to each face, representing an increasing level of pain.

    Time frame: Immediately after completion of the in-office bleaching session.

Secondary outcomes

  1. Change From Baseline in Visual Tooth Shade Immediately After Bleaching

    Tooth shade was assessed using the VITA Bleachedguide 3D-Master® classic guide. Shade tabs were converted into ordered numerical shade units. The change from baseline to immediately after treatment was calculated, with a greater reduction in shade units indicating greater whitening.

    Time frame: Tooth color assessments were conducted at baseline, immediately post-bleaching treatment.

  2. Spectrophotometric Tooth Color Change Immediately After Bleaching

    Tooth color was measured using a spectrophotometer at baseline and immediately after treatment. Color difference was calculated using the metric ΔE\*ab, ΔE00. Higher values indicated a greater color difference from baseline.

    Time frame: Baseline and immediately after the bleaching session.

  3. Tooth Color Stability During the Six-Month Follow-Up

    Tooth shade was assessed immediately after treatment and at 4 weeks, 8 weeks, and 6 months. Shade regression was calculated as the change between the immediate post-treatment shade and each follow-up measurement. Greater shade regression indicated greater loss of the whitening effect.

    Time frame: Immediately after treatment and at 4 weeks, 8 weeks, and 6 months.

  4. Spectrophotometric Color Stability During Follow-Up

    Spectrophotometric tooth-color measurements were obtained immediately after treatment and at 4 weeks, 8 weeks, and 6 months. Color stability was assessed by calculating the change in spectrophotometric shade scores between successive assessment periods. Greater positive changes during follow-up indicated greater shade regression and loss of the whitening effect.

    Time frame: Immediately after treatment and at 4 weeks, 8 weeks, and 6 months.

  5. Participant Satisfaction With the Bleaching Treatment

    Participants rated their overall satisfaction using a verbal rating scale with the following scores: 1 for extremely satisfied, 2 for satisfied, 3 not satisfied.

    Time frame: At the end of follow-up, 6 months after treatment.

07

Study locations

1 site
  • Faculty of Dentistry, Misr University for Science and Technology
    Giza, Giza Governorate, Egypt
08

References and documents

Publications

  • Goldberg M, Grootveld M, Lynch E. Undesirable and adverse effects of tooth-whitening products: a review. Clin Oral Investig. 2010 Feb;14(1):1-10. doi: 10.1007/s00784-009-0302-4. Epub 2009 Jun 20. PubMed 19543926 ↗
  • Gottenbos B, de Witz C, Heintzmann S, Born M, Hotzl S. Insights into blue light accelerated tooth whitening. Heliyon. 2021 Feb 10;7(2):e05913. doi: 10.1016/j.heliyon.2021.e05913. eCollection 2021 Feb. PubMed 33615002 ↗
  • Saberi S, Rouzsaz M, Shafie F, Einizadeh S, Kharazifard MJ, Shahabi S. The effect of laser-activated bleaching with 445 nm and 915 nm diode lasers on enamel micro-hardness; an in vitro study. Photodiagnosis Photodyn Ther. 2020 Sep;31:101952. doi: 10.1016/j.pdpdt.2020.101952. Epub 2020 Aug 18. PubMed 32818641 ↗
  • Drost T, Reimann S, Frentzen M, Meister J. Effectiveness of photopolymerization in composite resins using a novel 445-nm diode laser in comparison to LED and halogen bulb technology. Lasers Med Sci. 2019 Jun;34(4):729-736. doi: 10.1007/s10103-018-2651-1. Epub 2018 Oct 6. PubMed 30291465 ↗
  • Katalinic I, Budimir A, Bosnjak Z, Jakovljevic S, Anic I. The photo-activated and photo-thermal effect of the 445/970 nm diode laser on the mixed biofilm inside root canals of human teeth in vitro: A pilot study. Photodiagnosis Photodyn Ther. 2019 Jun;26:277-283. doi: 10.1016/j.pdpdt.2019.04.014. Epub 2019 Apr 14. PubMed 30995521 ↗
  • Al-Maliky MA, Frentzen M, Meister J. Artificial Caries Resistance in Enamel after Topical Fluoride Treatment and 445 nm Laser Irradiation. Biomed Res Int. 2019 Nov 3;2019:9101642. doi: 10.1155/2019/9101642. eCollection 2019. PubMed 31781651 ↗
  • De Moor RJ, Verheyen J, Verheyen P, Diachuk A, Meire MA, De Coster PJ, De Bruyne M, Keulemans F. Laser teeth bleaching: evaluation of eventual side effects on enamel and the pulp and the efficiency in vitro and in vivo. ScientificWorldJournal. 2015;2015:835405. doi: 10.1155/2015/835405. Epub 2015 Mar 22. PubMed 25874258 ↗
  • Buchalla W, Attin T. External bleaching therapy with activation by heat, light or laser--a systematic review. Dent Mater. 2007 May;23(5):586-96. doi: 10.1016/j.dental.2006.03.018. Epub 2006 Jul 3. PubMed 16820199 ↗
  • Fekrazad R, Alimazandarani S, Kalhori KA, Assadian H, Mirmohammadi SM. Comparison of laser and power bleaching techniques in tooth color change. J Clin Exp Dent. 2017 Apr 1;9(4):e511-e515. doi: 10.4317/jced.53435. eCollection 2017 Apr. PubMed 28469814 ↗
  • Joiner A. The bleaching of teeth: a review of the literature. J Dent. 2006 Aug;34(7):412-9. doi: 10.1016/j.jdent.2006.02.002. Epub 2006 Mar 29. PubMed 16569473 ↗
  • Haywood VB, Heymann HO. Nightguard vital bleaching: how safe is it? Quintessence Int. 1991 Jul;22(7):515-23. PubMed 1882044 ↗
  • Tooth whitening/bleaching: treatment considerations for dentists and their patients. ADA Council on Scientific Affairs. Sept 2009 (revised Nov 2010), p. 1-12.

Individual participant data

Plan to share: Undecided

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07870317
Lead sponsor
Misr University for Science and Technology
Responsible party
Shahd Amr ElHadidy (Master's Degree Candidate, Misr University for Science and Technology) — Principal investigator
First posted
Oct 13, 2026
Start date
Sep 4, 2024
Primary completion
Oct 21, 2024
Completion
Apr 21, 2025
Last update
Oct 13, 2026

Study contacts

Shahd A ElHadidy, BDS
principal investigator · Misr University for Science and Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion